The Cobas e 801 module from Roche, Basel, Switzerland, is a dedicated, high-volume immunoassay system now available for countries accepting the CE mark.
As diagnostic laboratories evolve to meet growing workloads in an increasingly challenging environment, the module offers flexibility, enabling the efficient use of existing resources such as space, infrastructure, and personnel. Designed for maximum consolidation of high-throughput continuous operation, the module also reduces the amount of waste generated, for more environmentally friendly testing.
“Today, laboratories need to deliver more diagnostic tests than ever before, while in many cases their resources are constrained,” says Roland Diggelmann, CEO of Roche Diagnostics. “The Cobas e 801 module is an important part of Roche’s connected laboratory solutions that allows laboratories to test efficiently and to sustainably grow their testing capacity.”
The module almost doubles the company’s currently available immunochemistry testing capacity on the same footprint. The system requires a low sample volume, offers an extensive assay menu, and delivers fast, reliable, and consistent patient results across systems.
The newest member of the Cobas 8000 modular analyzer series, the module offers more than 100 immunoassays across a wide range of disease areas. Up to four Cobas e 801 modules can be configured in series, delivering up to 1,200 tests per hour across up to 192 reagent positions. The module allows for continuous loading of reagents and consumables, and has a high uptime while requiring less hands-on time. The turnaround time for routine tests is 18 minutes, while emergency tests can be processed in just 9 minutes, with cardiac markers.
The module is not yet available in the United States. According to a spokesperson, US availability is anticipated in 2017.
For more information, visit AACC booth 1301 or Roche.
